We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter
Est. Return
+11.11%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$585M
AUM Growth
+$56.2M
(+11%)
Cap. Flow
+$17.6M
Cap. Flow
% of AUM
3.01%
Top 10 Holdings %
Top 10 Hldgs %
17.05%
Holding
830
New
329
Increased
104
Reduced
143
Closed
252
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$33.9M |
| 2 |
Verizon
VZ
|
+$6.56M |
| 3 |
Lowe's Companies
LOW
|
+$6.21M |
| 4 |
Procter & Gamble
PG
|
+$6.15M |
| 5 |
Danaher
DHR
|
+$5.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$12.8M |
| 2 |
Meta Platforms (Facebook)
META
|
+$11.3M |
| 3 |
Apple
AAPL
|
+$11.1M |
| 4 |
UnitedHealth
UNH
|
+$9.36M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$6.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.76% |
| 2 | Consumer Discretionary | 14.7% |
| 3 | Healthcare | 14.64% |
| 4 | Consumer Staples | 12.4% |
| 5 | Miscellaneous | 11.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NUVA
176
DELISTED
NuVasive, Inc.
NUVA
| $998K | 0.17% |
+12,900
| New | +$911K |
|
177
Guardant Health
GH
$22.6B
| $993K | 0.17% |
12,714
-18,100
| -59% | -$1.3M |
|
|
AYX
178
DELISTED
Alteryx Inc
AYX
| $981K | 0.17% |
+9,800
| New | +$996K |
|
179
Truist Financial
TFC
$61.4B
| $974K | 0.17% |
+17,300
| New | +$937K |
|
180
Hasbro
HAS
$13.3B
| $972K | 0.17% |
9,200
-28,800
| -76% | -$3M |
|
181
Northern Trust
NTRS
$34.1B
| $970K | 0.17% |
+9,130
| New | +$935K |
|
182
Southwest Airlines
LUV
$19.5B
| $967K | 0.17% |
+17,905
| New | +$993K |
|
|
SAIL
183
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $965K | 0.17% |
+40,900
| New | +$894K |
|
184
IBM
IBM
$225B
| $960K | 0.16% |
+7,492
| New | +$974K |
|
|
COUP
185
DELISTED
Coupa Software Incorporated
COUP
| $951K | 0.16% |
6,500
-12,700
| -66% | -$1.81M |
|
186
Quest Diagnostics
DGX
$27B
| $950K | 0.16% |
8,900
+2,200
| +33% | +$229K |
|
187
Five Below
FIVE
$13.7B
| $942K | 0.16% |
7,369
+2,664
| +57% | +$334K |
|
188
Johnson Controls International
JCI
$86.1B
| $940K | 0.16% |
23,100
-22,200
| -49% | -$937K |
|
189
NRG Energy
NRG
$24.1B
| $934K | 0.16% |
+23,500
| New | +$929K |
|
190
Incyte
INCY
$25.9B
| $919K | 0.16% |
10,519
+5,442
| +107% | +$465K |
|
191
Ambarella
AMBA
$3.12B
| $910K | 0.16% |
15,033
-1,900
| -11% | -$105K |
|
|
SKX
192
DELISTED
Skechers
SKX
| $909K | 0.16% |
+21,038
| New | +$830K |
|
|
SPLK
193
DELISTED
Splunk Inc
SPLK
| $899K | 0.15% |
+6,000
| New | +$788K |
|
194
FTI Consulting
FCN
$4.2B
| $894K | 0.15% |
8,078
+4,922
| +156% | +$538K |
|
195
Sally Beauty Holdings
SBH
$1.54B
| $887K | 0.15% |
+48,585
| New | +$845K |
|
196
Haemonetics
HAE
$4.78B
| $885K | 0.15% |
7,700
+4,200
| +120% | +$508K |
|
197
Post Holdings
POST
$3.69B
| $879K | 0.15% |
+12,310
| New | +$842K |
|
198
Ubiquiti
UI
$35.9B
| $869K | 0.15% |
+4,600
| New | +$742K |
|
199
SBA Communications
SBAC
$19.8B
| $868K | 0.15% |
3,600
-1,300
| -27% | -$308K |
|
200
Vanguard S&P 500 ETF
VOO
$1.03T
| $867K | 0.15% |
+2,930
| New | +$829K |
|
Similar funds
MCM
MFG
AFW
ADBIC
HSM
FWM
PIA
CCP
Bayesian Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Bayesian Capital Management held 830 positions worth $585M, up 11% from $529M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Bayesian Capital Management deployed $17.6M of net new capital in Q4 2019, opening 329 new positions and adding to 104 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 110,200 shares worth $35.5M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $11.3M trimmed.
- Bayesian Capital Management's largest Q4 2019 buy was State Street SPDR S&P 500 ETF Trust: 110,200 shares worth $35.5M.
- Bayesian Capital Management added most to Edwards Lifesciences in Q4 2019, an estimated $4.47M increase.
- Bayesian Capital Management's biggest Q4 2019 reduction was Meta Platforms (Facebook), cutting an estimated $11.3M.
- Bayesian Capital Management fully exited Accenture in Q4 2019, selling an estimated $12.8M.
- Bayesian Capital Management's ten largest holdings make up 17% of its $585M portfolio in Q4 2019.
- Bayesian Capital Management opened 329 new positions and closed 252 in Q4 2019.
- Bayesian Capital Management's portfolio value rose 11% quarter-over-quarter to $585M.
Based on Bayesian Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.